Drug-Target Information
Drug Name Target Name Drug Type Target Type Source Drug MeSHID Interaction Score Drug Status Target Action
acalabrutinib tyrosine-protein kinase btk small molecule Successful target TTD , drugbank , DGIDB Malignant lymphoma
lymphocytic
intermediate differentiation
diffuse[MeSHID:D020522]
Chronic Lymphocytic Leukemia[MeSHID:D015451]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 0.26 approved,investigational inhibitor
acalabrutinib tyrosine-protein kinase btk small molecule Successful target TTD , drugbank , DGIDB Malignant lymphoma
lymphocytic
intermediate differentiation
diffuse[MeSHID:D020522]
Chronic Lymphocytic Leukemia[MeSHID:D015451]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
leukemia[MeSHID:D007938]
Coronavirus Infections[MeSHID:D018352]
Disease[MeSHID:D004194]		 0.26 approved,investigational inhibitor
click here to return to the previous page